Published in

The American Spinal Injury Association, Topics in Spinal Cord Injury Rehabilitation, 2(6), p. 42-51, 2000

DOI: 10.1310/9a0a-e7p8-bapd-l8pm

SAGE Publications, Neurorehabilitation and Neural Repair, 4(14), p. 265-275, 2000

DOI: 10.1177/154596830001400403

Links

Tools

Export citation

Search in Google Scholar

Neurotrophic Factors and Gene Therapy in Spinal Cord Injury

Journal article published in 2000 by Armin Blesch ORCID, Steve Lacroix ORCID, Mark H. Tuszynski
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Although it was once thought that the central nervous system (CNS) of mammals was incapable of substantial recovery from injury, it is now clear that the adult CNS remains responsive to various substances that can promote cell survival and stimulate axonal growth. Among these substances are growth factors, including the neurotrophins and cytokines, and growth-supportive cells such as Schwann cells, olfactory ensheathing glia, and stem cells. We review the effects of these substances on promoting axonal growth after spinal cord injury, placing particular emphasis on the genetic delivery of nervous system growth factors to specific sites of injury as a means of promoting axonal growth and, in limited instances, functional recovery.